BioLargo’s Clyra Medical forms alliance with Advanced Solution

BioLargo (BLGO) announced its subsidiary Clyra Medical Technologies, had signed an exclusive stocking distribution agreement with Advanced Solution. This alliance will leverage Advanced Solution’s national network to distribute and promote ViaCLYR, Clyra’s wound irrigation solution, throughout the United States. ViaCLYR features Clyra’s proprietary Clyrasept technology, a copper-iodine complex which is an antimicrobial in solution as a preservative, effective against a broad spectrum of infection-causing organisms. The Clyrasept technology has demonstrated safety, efficacy, biocompatibility, and cost-effectiveness in its FDA-cleared applications, making it an ideal addition to modern wound care protocols. The alliance leverages the complementary strengths of both companies – combining Clyra’s innovative wound care technology with Advanced Solution’s proven distribution network and clinical training expertise – to create a nationwide platform for adoption. ViaCLYR is scheduled for market launch in early 2026.